EDGAR Filing Documents for 0001193125-22-220066

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-22-220066

Filing Date

2022-08-12

Accepted

2022-08-12 17:02:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d286456ds3.htm	S-3	440180
2	EX-1.2	d286456dex12.htm	EX-1.2	190052
3	EX-3.1	d286456dex31.htm	EX-3.1	76873
4	EX-4.2	d286456dex42.htm	EX-4.2	285268
5	EX-4.4	d286456dex44.htm	EX-4.4	89089
6	EX-4.5	d286456dex45.htm	EX-4.5	94428
7	EX-4.6	d286456dex46.htm	EX-4.6	84237
8	EX-5.1	d286456dex51.htm	EX-5.1	18212
9	EX-5.2	d286456dex52.htm	EX-5.2	5970
10	EX-23.1	d286456dex231.htm	EX-23.1	1675
11	EX-FILING FEES	d286456dexfilingfees.htm	EX-FILING FEES	29094
12	GRAPHIC	g286456g01a03.jpg	GRAPHIC	149944
13	GRAPHIC	g286456g01a04.jpg	GRAPHIC	66216
14	GRAPHIC	g286456newimg001.jpg	GRAPHIC	27430
	Complete submission text file	0001193125-22-220066.txt		1647952

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054

Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099

Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)